CNX Resources’s (NYSE:CNX) Q2 CY2026: Strong Sales
CNX Resources (NYSE:CNX) reported Q2 CY2026 results. Revenue rose 29.2% year on year to $618.5 million and exceeded Wall Street estimates by 29.2%, according to the company. GAAP profit was $1.32 per share, above consensus. The article also cites Q2 free cash flow of $137.5 million and an adjusted EBITDA margin of 67.6%.
How this was made

The 30-second read
Why it matters
The reported Q2 beat on revenue, GAAP EPS, adjusted EBITDA, and cash profitability can drive near-term sentiment and valuation support, but traders still need forward guidance and production/capex trajectory to judge durability.
Market read
A company-specific earnings beat with strong profitability and cash-flow metrics can prompt re-rating and momentum trading in CNX and peer upstream gas names.
What to watch
No guidance, production volumes, hedging details, or capex outlook are provided, which are key for sustaining the cash-flow strength into subsequent quarters.
Background
CNX Resources is a natural gas producer operating in Pennsylvania, Ohio, and West Virginia.
Ticker impact
CNX Resources reported Q2 CY2026 revenue up 29.2% to $618.5 million and GAAP EPS $1.32, beating consensus.
Likely supports continued upside bias versus peers, though magnitude depends on how much of the beat is commodity-driven.
The article provides multiple beat metrics (revenue, EPS, adjusted EBITDA) plus cash generation (FCF $137.5 million, 22.2% margin) and notes the stock rose 1.2% to $35.11 immediately after reporting.
Market effects
Upstream natural gas producers may see read-across demand for cost discipline and cash-flow stability metrics.
Limited direct regional spillover beyond US natural gas equities sentiment.
Low; primarily affects US-listed upstream gas equity positioning.
Counterpoint
The article flags free cash flow margin down year over year by 13 percentage points, suggesting the beat may be partly timing or commodity/hedge effects.
Key entities
- public_companyCNX Resources
US-listed natural gas producer reporting Q2 CY2026 results.



